Vanguard Group Inc Neuronetics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STIM
# of Institutions
68Shares Held
18.4MCall Options Held
200Put Options Held
3.6K-
Archon Capital Management LLC Seattle, WA2.54MShares$4.57 Million4.16% of portfolio
-
Cannell Capital LLC Alta, WY2.46MShares$4.43 Million2.78% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.54MShares$2.77 Million1.85% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.18MShares$2.12 Million0.04% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.17MShares$2.11 Million0.01% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $48.6M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...